Saxenda is a GLP-1 receptor agonist administered as a daily subcutaneous injection for weight management in adults with BMI 30 kg/m or 27 kg/m with comorbidities Lumps commonly result from localised inflammation, lipohypertrophy from repeated injections in the same area, or rarely from infection or improper technique Prevention requires rotating injection sites within the abdomen, thigh, or upper arm, maintaining at least 1 cm distance between consecutive injections Proper technique includes using a new needle each time, injecting at 90 degrees, and keeping the needle in skin for at least 6 seconds after injection Most lumps resolve spontaneously with site avoidance
BID dosing may be split AM/PM
Dosing for pernicious anemia or food-bound cobalamin malabsorption is 1000 mcg/day
What your body does with them is not
A decision on whether to continue/discontinue breastfeeding or to continue/discontinue therapy should be made on an individual basis, taking into account the womans choice, the drug profile, the benefit of breastfeeding to the child, and the benefit of therapy to the woman[118]
[88] Lowering your intake of dietary iron, as well as eating phytates and oxalates with iron-rich foods, may be helpful for some, but it is not usually curative and can also prevent the absorption of other nutrients such as zinc and calcium